{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey on Demographics & Best Practices in the Management of Acid Peptic Diseases

Doctor’s details
@if(isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What is the profile of patients you typically see with Acid Peptic Diseases (APD)? *

    2. a. Most common Age Range

    b. Gender (% of patients)

    Male
    %
    Female
    %

    c. Geographic location

  2. In your practice, do you observe any gender differences in the presentation of APD? *

  3. How often do you find APD in your patient population? *

  4. Do you inquire about lifestyle factors such as smoking, alcohol consumption, stress levels, etc. during patient consultations? *

  5. How do you educate the patients on the impact of lifestyle factors in developing or exacerbating APD? *
  6. What are the typical dietary patterns or habits observed in patients with APD? *

  7. What challenges do you face in managing patients with APD in your practice? *

  8. Have you observed any differences in the prevalence of APD among different age groups? *

  9. Have you observed any differences in the prevalence of APD among different ethnic groups? *

  10. What is the current trend in prescription patterns for APD management in your practice? *

  11. How often do you encounter patients with refractory APD (i.e., symptoms persist despite treatment)? *

  12. What is your approach to patients with refractory APD (i.e., symptoms persist despite treatment)? *

  13. Which are the most common overlap conditions observed in your GERD patients? (More than one option can be selected) *

  14. Which class of medications is commonly used as first-line therapy for GERD? *

  15. Do you consider combining PPI and prokinetics in a particular patient population/profile? *
  16. In such a subset of patients, which Prokinetic do you prefer? *

  17. What percentage of your APD patients are prescribed PPI? *

  18. Of the above, what percentage of your patients are prescribed a combination of PPI+Prokinetic? *

  19. Which type of patients, would you choose to administer IV Pantoprazole? (Please select more than one option if applicable) *

  20. Do you consider de-escalating treatment in patients with APD who have achieved symptom control? *

  21. In your practice, when do you consider/recommend surgical intervention for patients with APD? (More than one option can be selected) *

  22. What strategies do you use to promote patient adherence to lifestyle modifications & medication? *
  23. What parameters do you monitor during follow-up visits to assess treatment efficacy? (More than one option can be selected) *

  24. What % of patients present with comorbidities in your practice? *

  25. What are the common co-morbidities you encounter in APD patients? *
  26. Which PPI do you prefer in patients with comorbidities? *

  27. How do you manage or mitigate side effects associated with acid-neutralizing medications in your patients? *

  28. In your experience, which class of acid-neutralizing medications tends to have the fewest side effects? *

  29. How do you prioritize the management of side effects when selecting acid-neutralizing therapy for your patients? *

  30. What considerations guide your APD management when personalizing treatment regimens? *
  31. What specific lifestyle recommendations do you provide patients, and how do you assess their adherence to them? *
  32. How do you stay updated on the latest advancements and incorporate them into your clinical practice? *

  33. Do you utilize patient-reported outcomes (e.g., symptom severity scales, and quality of life assessments) to evaluate the impact of APD on patients' daily lives? *
  34. What are the primary barriers or challenges patients with APD encounter in adhering to prescribed treatment regimens? *
  35. What recommendations/resources do you offer to improve patient's overall quality of life while managing their condition? *
  36. How do you assess patient satisfaction with the care provided for APD? *
  37. What educational resources or materials do you provide patients to enhance their understanding of APD and self-management strategies? *
  38. What are the unmet needs or gaps in the current management of APD? *

  39. Do you assess the psychosocial impact of APD on patients, including factors such as anxiety, depression, or social functioning? *
  40. Are there any emerging therapies or research developments in APD management that you find particularly promising? *